Amplia Therapeutics Limited
Amplia Therapeutics Limited (INNMF) Stock Technical Analysis & Trading Signals
Live technical indicators, trading signals, and momentum insights for Amplia Therapeutics Limited (PNK:INNMF).
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerINNMF Technical Analysis Summary
Amplia Therapeutics Limited stock currently shows a bullish trend, supported by momentum and strong buying pressure.
Overall, Amplia Therapeutics Limited remains neutral, with indicators showing mixed momentum.
RSI (14): 65.13
Stochastic %K: 53.86
Williams %R: -44.74
Rate of Change (ROC): 94.74
Takeaway:Amplia Therapeutics Limited shows neutral momentum, with indicators pointing to indecision.
MACD: 0.02
ADX: 38.21
ATR (14): 0.02
CCI (14): 76.22
Takeaway:Amplia Therapeutics Limited shows a firm trend supported by momentum, though one signal suggests caution.
Takeaway:Amplia Therapeutics Limited trades closer to resistance, supported by stronger momentum within bands.
Takeaway:Amplia Therapeutics Limited trades near the upper channel, signaling resistance and risk of pullback.
Overall Takeaway:INNMF shows mixed signals in money flow analysis.
Bullish Signals
RSI above 50 → positive momentum from buyers.
MACD above 0 → bullish trend confirmation.
ADX above 20 → strong underlying trend.
Price trading above middle Bollinger Band → mid-term support intact.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
RVI below 50 → vigor tilted toward sellers.
Overall Recommendation:Amplia Therapeutics Limited currently shows a Buy with caution signal — momentum and trend strength are positive, but price is close to resistance and may face short-term pullbacks.